| Title |
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
|
|---|---|
| Published in |
The Lancet Rheumatology, May 2020
|
| DOI | 10.1016/s2665-9913(20)30127-2 |
| Pubmed ID | |
| Authors |
Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, Emanuel Della-Torre, Marco Ripa, Diana Canetti, Chiara Oltolini, Barbara Castiglioni, Chiara Tassan Din, Nicola Boffini, Alessandro Tomelleri, Nicola Farina, Annalisa Ruggeri, Patrizia Rovere-Querini, Giuseppe Di Lucca, Sabina Martinenghi, Raffaella Scotti, Moreno Tresoldi, Fabio Ciceri, Giovanni Landoni, Alberto Zangrillo, Paolo Scarpellini, Lorenzo Dagna |
X Demographics
The data shown below were collected from the profiles of 654 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 103 | 16% |
| Italy | 34 | 5% |
| Japan | 34 | 5% |
| United Kingdom | 32 | 5% |
| Spain | 25 | 4% |
| France | 22 | 3% |
| Mexico | 17 | 3% |
| Brazil | 15 | 2% |
| Canada | 12 | 2% |
| Other | 84 | 13% |
| Unknown | 276 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 480 | 73% |
| Scientists | 91 | 14% |
| Practitioners (doctors, other healthcare professionals) | 72 | 11% |
| Science communicators (journalists, bloggers, editors) | 10 | 2% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 771 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 771 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 101 | 13% |
| Student > Bachelor | 83 | 11% |
| Other | 68 | 9% |
| Student > Ph. D. Student | 65 | 8% |
| Student > Master | 63 | 8% |
| Other | 162 | 21% |
| Unknown | 229 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 258 | 33% |
| Biochemistry, Genetics and Molecular Biology | 51 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 42 | 5% |
| Immunology and Microbiology | 35 | 5% |
| Nursing and Health Professions | 30 | 4% |
| Other | 96 | 12% |
| Unknown | 259 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 634. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2024.
All research outputs
#35,557
of 25,836,587 outputs
Outputs from The Lancet Rheumatology
#17
of 905 outputs
Outputs of similar age
#1,590
of 416,707 outputs
Outputs of similar age from The Lancet Rheumatology
#2
of 60 outputs
Altmetric has tracked 25,836,587 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 905 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 53.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 416,707 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.